Show simple item record

dc.contributor.advisorAmatruda, James F.en
dc.creatorReynoso, Eduardoen
dc.date.accessioned2020-01-02T18:19:47Z
dc.date.available2020-01-02T18:19:47Z
dc.date.created2017-12
dc.date.issued2017-07-13
dc.date.submittedDecember 2017
dc.identifier.urihttps://hdl.handle.net/2152.5/7729
dc.description.abstractNecroptosis is an immunogenic caspase-independent cell death program. While mainly serving to defend against viral infection, dysregulated necroptotic signaling contributes to the pathology of a growing number of human diseases associated with inflammation, neurodegeneration, and ischemic injuries. Since its emergence, many key components of the mammalian necroptotic pathway have been discovered including RIP1/3 kinases and MLKL, which together, form the core of the necrosome complex. RIP3-dependent phosphorylation of MLKL promotes the formation of high molecular weight MLKL polymers that disrupt the integrity of the plasma membrane leading to cell death. However, the mechanistic details of MLKL polymerization and its precise function in executing necroptosis remain poorly understood. To gain insight into this process, the crosslinking property of the specific MLKL inhibitor Necrosulfonamide (NSA) was exploited as a strategy for identifying novel MLKL interacting proteins. Immunoprecipitation of NSA crosslinked MLKL complexes followed by mass spectrometric analysis revealed Thioredoxin-1, an essential cytosolic thiol oxidoreductase, to be a potential MLKL regulator. Based on its ability to reduce disulfide bonds on specific protein targets, it was hypothesized that Thioredoxin-1 actively maintains MLKL in a reduced monomeric state to suppress the occurrence of spontaneous necroptosis. Therefore, genetic and pharmacological approaches were taken to perturb Thioredoxin-1 activity as a means for testing whether it would induce necroptosis in human cells. The data presented here demonstrates that inhibiting Thioreoxin-1 activity using the compound PX-12 promoted RIP3-dependent MLKL S358 phosphorylation, polymer formation, and caspase-independent necrotic cell death. Additionally, PX12-induced cell death was rescued by co-treating cells with NSA highlighting the involvement of MLKL in this cell death pathway. These results were corroborated by shRNA-mediated knockdown of Thioreoxin-1 mRNA. Altogether, these findings point to Thioredoxin-1 as a critical regulator of MLKL activity and necroptosis in human cells.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.subjectNeoplasm Proteinsen
dc.subjectNeoplasmsen
dc.subjectProtein Kinasesen
dc.subjectProtein Multimerizationen
dc.subjectThioredoxinsen
dc.titleThioredoxin-1 Inhibition Promotes MLKL Activation: Biochemical Insights Into a Suppressor of the Necroptotic Pathwayen
dc.typeThesisen
dc.date.updated2020-01-02T18:19:47Z
dc.type.materialtexten
thesis.degree.grantorUT Southwestern Medical Centeren
thesis.degree.departmentGraduate School of Biomedical Sciencesen
thesis.degree.nameDoctor of Philosophyen
thesis.degree.levelDoctoralen
thesis.degree.disciplineGenetics and Developmenten
dc.contributor.committeeMemberWang, Zhigaoen
dc.contributor.committeeMemberAbrams, John M.en
dc.contributor.committeeMemberChen, Zhijian J.en
dc.identifier.oclc1134689297


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record